PATENT CLAIM ANALYSIS

Application Number: 15874396
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "044000"]

Abstract:
The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.

Claim (Index 19):
A method of treating a human subject having a pathological state mediated at least in part by alpha-ENaC expression, the method comprising the step of administering to the subject a therapeutically effective amount of a composition of  claim 4 .

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15260824', '12683146', '14729104', '12771614', '12771566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8126654966647315
- 35 USC 102 Novelty (BERT): 0.5504541764471191
- Combined Prediction Score: 0.7864443646429703
- Mean Citation Score: 410.52154
- Max Citation Score: 416.51477
- Similarity Product: 367.32817927745583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test